These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 73397)

  • 21. Androgens and estrogens in the plasma and prostatic tissue of normal dogs and dogs with benign prostatic hypertrophy.
    Lloyd JW; Thomas JA; Mawhinney MG
    Invest Urol; 1975 Nov; 13(3):220-22. PubMed ID: 53217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum steroids in normal males and patients with prostatic diseases.
    Hammond GL; Kontturi M; Vihko P; Vihko R
    Clin Endocrinol (Oxf); 1978 Aug; 9(2):113-21. PubMed ID: 81115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgens in patients with benign prostatic hyperplasia before and after prostatectomy.
    Vermeulen A; De Sy W
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1250-4. PubMed ID: 63468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bawu decoction () ameliorates benign prostatic hyperplasia in rats.
    Eom JH; Cheon SY; Chung KS; Kim MD; An HJ
    Chin J Integr Med; 2017 Aug; 23(8):611-616. PubMed ID: 27838873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro studies of testosterone and 5alpha-dihydrotestosterone binding in benign prostatic hypertrophy.
    Steins P; Krieg M; Hollmann HJ; Voigt KD
    Acta Endocrinol (Copenh); 1974 Apr; 75(4):773-84. PubMed ID: 4136809
    [No Abstract]   [Full Text] [Related]  

  • 26. Peripheral and prostatic vein steroid concentrations in benign prostatic hypertrophy patients before and after removal of the adenoma.
    Lukkarinen O; Hammond GL; Kontturi M; Vihko R
    Scand J Urol Nephrol; 1980; 14(3):225-7. PubMed ID: 6163202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men.
    Trifiro MD; Parsons JK; Palazzi-Churas K; Bergstrom J; Lakin C; Barrett-Connor E
    BJU Int; 2010 Jun; 105(11):1554-9. PubMed ID: 20002438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
    Ghanadian R; Puah CM
    J Endocrinol; 1981 Feb; 88(2):255-62. PubMed ID: 6162906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered blood androgens in elderly men with prostate hyperplasia.
    Horton R; Hsieh P; Barberia J; Pages L; Cosgrove M
    J Clin Endocrinol Metab; 1975 Oct; 41(4):793-6. PubMed ID: 1176586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
    Cochran RC; Ewing LL; Niswender GD
    Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hormonal disturbances in men with a prostatic adenoma (author's transl)].
    Baranowska B; Zgliczynski S; Szymanowski J
    J Urol (Paris); 1980; 86(7):551-8. PubMed ID: 6161196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating unconjugated 5 alpha-androstane-3 alpha, 17 beta-diol in elderly men and patients with prostatic tumours.
    Puah CM; Ghanadian R
    Age Ageing; 1983 Aug; 12(3):201-5. PubMed ID: 6194676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor.
    Clark RV; Hermann DJ; Cunningham GR; Wilson TH; Morrill BB; Hobbs S
    J Clin Endocrinol Metab; 2004 May; 89(5):2179-84. PubMed ID: 15126539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone blood levels and their inter-relationships in normal men and men with benign prostatic hyperplasia (BPH).
    Bartsch W; Becker H; Pinkenburg FA; Krieg M
    Acta Endocrinol (Copenh); 1979 Apr; 90(4):727-36. PubMed ID: 86267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-dependent change of serum 5alpha-dihydrotestosterone and its relation to testosterone in man.
    Nawata H; Kato K; Ibayashi H
    Endocrinol Jpn; 1977 Feb; 24(1):41-5. PubMed ID: 862570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats.
    Al-Trad B; Aljabali A; Al Zoubi M; Shehab M; Omari S
    Int J Nanomedicine; 2019; 14():3145-3154. PubMed ID: 31118628
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of dutasteride on lower urinary tract symptoms: a prospective analysis based on changes in testosterone/dihydrotestosterone levels and total prostatic volume reduction.
    Shigehara K; Miyagi T; Nakashima T; Izumi K; Kitagawa Y; Mizokami A; Koh E; Shimamura M; Namiki M
    Aging Male; 2016 Jun; 19(2):128-33. PubMed ID: 26890877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dihydrotestosterone and testosterone levels in men screened for prostate cancer: a study of a randomized population.
    Gustafsson O; Norming U; Gustafsson S; Eneroth P; Aström G; Nyman CR
    Br J Urol; 1996 Mar; 77(3):433-40. PubMed ID: 8814852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men.
    Kjaer TN; Ornstrup MJ; Poulsen MM; Jørgensen JO; Hougaard DM; Cohen AS; Neghabat S; Richelsen B; Pedersen SB
    Prostate; 2015 Sep; 75(12):1255-63. PubMed ID: 25939591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of tamoxifen on the levels of luteinizing hormone (LH), follicle stimulating hormone (FSH), prolactin (PRL), 17 beta-oestradiol (E2), total and free testosterone (T) and total and free dihydrotestosterone (DHT) in blood of patients with benign prostatic hyperplasia.
    Stahl F; Schnorr D; Rohde W; Poppe I; Geier T; Dörner G
    Exp Clin Endocrinol; 1983 Jul; 82(1):21-8. PubMed ID: 6193975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.